KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Cardlytics (CDLX) FCF Margin (2017 - 2025)

Historic FCF Margin for Cardlytics (CDLX) over the last 9 years, with Q3 2025 value amounting to 5.17%.

  • Cardlytics' FCF Margin fell 1500.0% to 5.17% in Q3 2025 from the same period last year, while for Sep 2025 it was 7.1%, marking a year-over-year increase of 16700.0%. This contributed to the annual value of 9.54% for FY2024, which is 56900.0% down from last year.
  • As of Q3 2025, Cardlytics' FCF Margin stood at 5.17%, which was down 1500.0% from 4.92% recorded in Q2 2025.
  • In the past 5 years, Cardlytics' FCF Margin registered a high of 3.89% during Q2 2023, and its lowest value of 32.39% during Q1 2022.
  • Its 5-year average for FCF Margin is 13.42%, with a median of 13.85% in 2022.
  • In the last 5 years, Cardlytics' FCF Margin crashed by -176500bps in 2021 and then surged by 216900bps in 2023.
  • Over the past 5 years, Cardlytics' FCF Margin (Quarter) stood at 3.27% in 2021, then crashed by -496bps to 19.48% in 2022, then soared by 97bps to 0.55% in 2023, then tumbled by -229bps to 1.8% in 2024, then tumbled by -187bps to 5.17% in 2025.
  • Its last three reported values are 5.17% in Q3 2025, 4.92% for Q2 2025, and 17.27% during Q1 2025.